﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>OncUView: Sort User Sumbitted Videos</title><link>http://www.oncology.tv/tabid/39/Default.aspx</link><description /><copyright>Copyright 2010-2013 by OncUView.tv, LLC</copyright><language>en-US</language><webMaster>Administrator Account</webMaster><pubDate>Tue, 21 May 2013 21:04:18 GMT</pubDate><generator>Ultra Video Gallery</generator><image><title>OncUView</title><link>http://www.oncology.tv</link><url>http://www.oncology.tv/Portals/0/headerRegistered.jpg</url></image><item><title>Current Treatment Landscape in Melanoma - interview with Howard Kaufman, MD, at ASCO 2012</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/442/Current-Treatment-Landscape-In-Melanoma-Interview-With-Howard-Kaufman-MD-At-ASCO-2012.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/snelson/634750875988727266.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the American Society of Clinical Oncology (ASCO) 2012, Howard Kaufman, MD, Director, Rush University Cancer Center, Chicago, discusses the current treatment landscape in melanoma.</description><author>Stephen Nelson</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/442/Current-Treatment-Landscape-In-Melanoma-Interview-With-Howard-Kaufman-MD-At-ASCO-2012.aspx</link><category>Melanoma</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/442/Current-Treatment-Landscape-In-Melanoma-Interview-With-Howard-Kaufman-MD-At-ASCO-2012.aspx#PostComment</comments><guid>442</guid><pubDate>Tue, 12 Jun 2012 08:46:40 GMT</pubDate></item><item><title>Lung Cancer - interview with Geoff Oxnard, MD, at ASCO 2012</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/441/Lung-Cancer-Interview-With-Geoff-Oxnard-MD-At-ASCO-2012.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/snelson/634750873699742891.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the American Society of Clinical Oncology (ASCO) 2012, Geoff Oxnard, MD, discusses how decisions are made about if and when to change the course of treatment.</description><author>Stephen Nelson</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/441/Lung-Cancer-Interview-With-Geoff-Oxnard-MD-At-ASCO-2012.aspx</link><category>Lung Cancer</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/441/Lung-Cancer-Interview-With-Geoff-Oxnard-MD-At-ASCO-2012.aspx#PostComment</comments><guid>441</guid><pubDate>Tue, 12 Jun 2012 08:42:53 GMT</pubDate></item><item><title>Update on JAK Inhibitor — Spleen Volume Reduction and OS interview with Srdan Verstovsek, MD, PhD, at ASH 2011</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/415/Update-On-JAK-Inhibitor--Spleen-Volume-Reduction-And-OS-Interview-With-Srdan-Verstovsek-MD-PhD-At-ASH-2011.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/snelson/634613680453259063.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the American Society of Hematology (ASH) 2011, Srdan Verstovsek, MD, PhD, discusses the results of the COMFORT I Study, which included consistent benefit of ruxolitinib over placebo in spleen volume reduction and symptom improvement across subgroups as well as overall survival advantage. Comparison of outcomes of advanced myelofibrosis patients treated with ruxolitinib to those of a historical control group is also discussed.&lt;br&gt;&lt;br&gt;

Accompanying this interview are two downloadable slide decks of the abstracts.
</description><author>Stephen Nelson</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/415/Update-On-JAK-Inhibitor--Spleen-Volume-Reduction-And-OS-Interview-With-Srdan-Verstovsek-MD-PhD-At-ASH-2011.aspx</link><category>Myeloproliferative Neoplasms (MPN)</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/415/Update-On-JAK-Inhibitor--Spleen-Volume-Reduction-And-OS-Interview-With-Srdan-Verstovsek-MD-PhD-At-ASH-2011.aspx#PostComment</comments><guid>415</guid><pubDate>Thu, 05 Jan 2012 13:47:28 GMT</pubDate></item><item><title>Colorectal Cancer and the CORRECT Trial - interview with Axel Grothey, MD, at ASCO 2012</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/434/Colorectal-Cancer-And-The-CORRECT-Trial-Interview-With-Axel-Grothey-MD-At-ASCO-2012.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/snelson/634750851420670625.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the American Society of Clinical Oncology (ASCO) 2012, Axel Grothey, MD, Mayo Clinic, MN, discusses colorectal cancer and the CORRECT trial.</description><author>Stephen Nelson</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/434/Colorectal-Cancer-And-The-CORRECT-Trial-Interview-With-Axel-Grothey-MD-At-ASCO-2012.aspx</link><category>Colorectal Cancer</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/434/Colorectal-Cancer-And-The-CORRECT-Trial-Interview-With-Axel-Grothey-MD-At-ASCO-2012.aspx#PostComment</comments><guid>434</guid><pubDate>Tue, 12 Jun 2012 08:05:45 GMT</pubDate></item><item><title>CINV - Chemotherapy-induced Nausea and Vomiting</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/432/CINV-Chemotherapyinduced-Nausea-And-Vomiting.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/rbieber/634747525238053438.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the Oncology Nursing Society (ONS) 2012, Anne Marie Shaftic, MSN, RN, Oncology Nurse Practitioner discusses the prevalence of CINV, benefits of various treatment options and key challenges facing health care practitioners in treating CINV. </description><author>Robert Bieber</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/432/CINV-Chemotherapyinduced-Nausea-And-Vomiting.aspx</link><category>Symptom Management</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/432/CINV-Chemotherapyinduced-Nausea-And-Vomiting.aspx#PostComment</comments><guid>432</guid><pubDate>Fri, 08 Jun 2012 11:42:05 GMT</pubDate></item><item><title>Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer - The Bolero-2 Trial - Mary E. Peterson, RN, MS, ANP-BC</title><description>&lt;a href='http://www.oncology.tv/Videos/TabId/79/VideoId/426/Everolimus-In-Postmenopausal-HormoneReceptorPositive-Advanced-Breast-Cancer-The-Bolero2-Trial-Mary-E-Peterson-RN-MS-ANPBC.aspx'&gt;&lt;img src='http://uvgvideo.s3.amazonaws.com/Portals/0/UltraVideoGallery/snelson/634746778239196016.gif' align='left' border='0' hspace='5'&gt;&lt;/a&gt;At the Oncology Nursing Society (ONS) 2012, Mary E. Peterson, RN, MS, ANP-BC, Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, discusses the Bolero-2 Trial</description><author>Stephen Nelson</author><link>http://www.oncology.tv/Videos/TabId/79/VideoId/426/Everolimus-In-Postmenopausal-HormoneReceptorPositive-Advanced-Breast-Cancer-The-Bolero2-Trial-Mary-E-Peterson-RN-MS-ANPBC.aspx</link><category>Breast Cancer</category><comments>http://www.oncology.tv/Videos/TabId/79/VideoId/426/Everolimus-In-Postmenopausal-HormoneReceptorPositive-Advanced-Breast-Cancer-The-Bolero2-Trial-Mary-E-Peterson-RN-MS-ANPBC.aspx#PostComment</comments><guid>426</guid><pubDate>Thu, 07 Jun 2012 14:57:05 GMT</pubDate></item></channel></rss>